BioOutsource and Cellca are now Sartorius Stedim Biotech
We are proud to announce BioOutsource and Cellca are now Sartorius Stedim Biotech providing a fully integrated cell line and upstream development service.
Sartorius Stedim Biotech, a leading supplier of products and services for the biopharmaceutical industry, acquired BioOutsource and Cellca to further expand their portfolio of innovative drug development services.
BioOutsource and Cellca provide a fully integrated portfolio of services to provide a total solution for biopharmaceutical drug development; BioOutsource are global leaders in contract testing & research services, and Cellca a leading provider of cell line development & upstream process. The joint business offering provides a total solution to support drug development, from early stage cell line development, GMP cell bank manufacture & characterization, analytical testing from clone selection, process development, characterization through to GMP lot release. Committed to offering a first class service package, Sartorius Stedim Biotech are consistently developing technology with their in-house R&D departments to expand their extensive technical expertise to address market demands.
Learn more about our expertise and service offering.
Sartorius Stedim Biotech – Upstream Development Services Locations
Glasgow, UK – BioOutsource Contract Testing Services & Cell Bank Manufacture
Laupheim, Germany – Cellca Cell Line Development & Upstream Process
Cambridge, USA – North America Bioanalytical and Biosafety Testing Services